2012
DOI: 10.1245/s10434-012-2560-7
|View full text |Cite
|
Sign up to set email alerts
|

Prognostication of Vulvar Cancer Based on p14ARF Status: Molecular Assessment of Transcript and Protein

Abstract: p14ARF represents an important marker of poor prognosis in VSCC. p53 and HPV infection did not show any prognostic importance. Further clinical trials concerning p14ARF positivity may result in important contributions due to its relationship with poor outcome. Mainly due to the relationship of p14ARF with lymph node metastasis, the immunohistochemistry evaluation of this marker may help to identify a subset of patients more suitable to less radical procedures.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
12
0

Year Published

2013
2013
2017
2017

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 41 publications
1
12
0
Order By: Relevance
“…These results, together with other results from our group, drive us to conclude that HPV-positive tumours do not show evidences of EMT-like events, with usually better prognosis (De Melo Maia et al , 2012; Lavorato-Rocha et al 2013). On the other hand, the HPV-negative tumours develop EMT-like and, therefore increased capability of invasion and progression, leading to worse prognosis and poorer outcome.…”
Section: Discussionsupporting
confidence: 79%
“…These results, together with other results from our group, drive us to conclude that HPV-positive tumours do not show evidences of EMT-like events, with usually better prognosis (De Melo Maia et al , 2012; Lavorato-Rocha et al 2013). On the other hand, the HPV-negative tumours develop EMT-like and, therefore increased capability of invasion and progression, leading to worse prognosis and poorer outcome.…”
Section: Discussionsupporting
confidence: 79%
“…The majority of studies ( n = 15) used formalin‐fixed paraffin‐embedded tissue samples for diagnosis and HPV testing. Most studies ( n = 14) used polymerase chain reaction (PCR)‐based test to detect HPV DNA, while two studies used in situ hybridization (ISH) and one study used hybrid capture 2 (HC2). Finally, one study used p16 immunohistochemistry (p16 IHC) as a surrogate marker for HPV infection …”
Section: Resultsmentioning
confidence: 99%
“…Despite the discovery of potential prognostic risk factors [16,17] LN involvement is still the most important prognostic factor in vulva carcinoma [1,[4][5][6]. Moreover, it is suggested that the amount of removed LNs is associated with GR rates.…”
Section: Discussionmentioning
confidence: 99%